Barclays PLC Sells 17,982 Shares of National Research Co. (NASDAQ:NRC)

Barclays PLC cut its stake in National Research Co. (NASDAQ:NRC) by 35.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,349 shares of the company’s stock after selling 17,982 shares during the quarter. Barclays PLC owned about 0.14% of National Research worth $588,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in NRC. JPMorgan Chase & Co. grew its holdings in shares of National Research by 8.7% in the third quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company’s stock worth $393,000 after acquiring an additional 1,373 shares during the period. QV Investors Inc. raised its holdings in shares of National Research by 4.5% in the fourth quarter. QV Investors Inc. now owns 354,360 shares of the company’s stock worth $6,251,000 after buying an additional 15,370 shares during the period. SG Americas Securities LLC raised its position in National Research by 35.0% during the 4th quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock valued at $129,000 after purchasing an additional 1,893 shares in the last quarter. Inspire Investing LLC lifted its holdings in shares of National Research by 26.1% in the 4th quarter. Inspire Investing LLC now owns 22,952 shares of the company’s stock worth $405,000 after buying an additional 4,746 shares during the period. Finally, Exchange Traded Concepts LLC grew its position in shares of National Research by 17.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 16,421 shares of the company’s stock worth $290,000 after buying an additional 2,412 shares in the last quarter. 47.26% of the stock is currently owned by institutional investors.

National Research Stock Performance

NRC stock opened at $13.42 on Friday. National Research Co. has a 1-year low of $9.76 and a 1-year high of $32.48. The business has a 50-day moving average price of $12.79 and a 200 day moving average price of $16.12. The company has a market capitalization of $307.94 million, a P/E ratio of 12.78 and a beta of 0.34. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Monday, April 28th. The company reported $0.25 earnings per share for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%. The firm had revenue of $33.55 million during the quarter.

National Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.48 dividend on an annualized basis and a yield of 3.58%. National Research’s payout ratio is 46.60%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.